| The role of STAT3 in autophagy L You, Z Wang, H Li, J Shou, Z Jing, J Xie, X Sui, H Pan, W Han Autophagy 11 (5), 729-739, 2015 | 449 | 2015 |
| Nuclear factor of activated T cells in cancer development and treatment J Shou, J Jing, J Xie, L You, Z Jing, J Yao, W Han, H Pan Cancer letters 361 (2), 174-184, 2015 | 125 | 2015 |
| Autophagy inhibition sensitizes hepatocellular carcinoma to the multikinase inhibitor linifanib H Pan, Z Wang, L Jiang, X Sui, L You, J Shou, Z Jing, J Xie, W Ge, X Cai, ... Scientific reports 4 (1), 6683, 2014 | 67 | 2014 |
| CircUBAP2-mediated competing endogenous RNA network modulates tumorigenesis in pancreatic adenocarcinoma R Zhao, J Ni, S Lu, S Jiang, L You, H Liu, J Shou, C Zhai, W Zhang, ... Aging (Albany NY) 11 (19), 8484, 2019 | 61 | 2019 |
| Cyclosporine A sensitizes human non-small cell lung cancer cells to gefitinib through inhibition of STAT3 J Shou, L You, J Yao, J Xie, J Jing, Z Jing, L Jiang, X Sui, H Pan, W Han Cancer letters 379 (1), 124-133, 2016 | 59 | 2016 |
| Crizotinib induces autophagy through inhibition of the STAT3 pathway in multiple lung cancer cell lines L You, J Shou, D Deng, L Jiang, Z Jing, J Yao, H Li, J Xie, Z Wang, Q Pan, ... Oncotarget 6 (37), 40268, 2015 | 56 | 2015 |
| Crosstalk between IGF-1R and other tumor promoting pathways C Liu, Z Zhang, H Tang, Z Jiang, L You, Y Liao Current pharmaceutical design 20 (17), 2912-2921, 2014 | 53 | 2014 |
| The roles of subcellularly located EGFR in autophagy H Li, L You, J Xie, H Pan, W Han Cellular signalling 35, 223-230, 2017 | 50 | 2017 |
| Analysis of potential genes and pathways associated with the colorectal normal mucosa–adenoma–carcinoma sequence Z Wu, Z Liu, W Ge, J Shou, L You, H Pan, W Han Cancer medicine 7 (6), 2555-2566, 2018 | 37 | 2018 |
| The efficacy and safety of anlotinib combined with PD-1 antibody for third-line or further-line treatment of patients with advanced non-small-cell lung cancer C Zhai, X Zhang, L Ren, L You, Q Pan, H Pan, W Han Frontiers in Oncology 10, 619010, 2021 | 18 | 2021 |
| Effects of insulin-like growth factor 1 receptor and its inhibitor AG1024 on the progress of lung cancer Y Wei, H Tang, Y Liao, S Fu, L Xu, G Chen, C Zhang, S Ju, Z Liu, L You, ... Journal of Huazhong University of Science and Technology [Medical Sciences …, 2015 | 17 | 2015 |
| Efficacy and safety of combined immunotherapy and antiangiogenic therapy for advanced non-small cell lung cancer: A two-center retrospective study J Yao, Z Wang, J Sheng, H Wang, L You, X Zhu, H Pan, W Han International Immunopharmacology 89, 107033, 2020 | 15 | 2020 |
| Advances in targeting insulin-like growth factor signaling pathway in cancer treatment L You, C Liu, H Tang, Y Liao, S Fu Current pharmaceutical design 20 (17), 2899-2911, 2014 | 15 | 2014 |
| Autophagy in colitis-associated colon cancer: exploring its potential role in reducing initiation and preventing IBD-Related CAC development X Jin, L You, J Qiao, W Han, H Pan Autophagy 20 (2), 242-258, 2024 | 8 | 2024 |
| Exploring the role of Mir204/211 in HNSCC by the combination of bioinformatic analysis of ceRNA and transcription factor regulation J Cai, Y Yu, Y Xu, H Liu, J Shou, L You, H Jiang, XF Han, B Xie, W Han Oral Oncology 96, 153-160, 2019 | 6 | 2019 |
| A microRNA disease signature associated with lymph node metastasis of lung adenocarcinoma SY Cen, KY Fu, Y Shi, HL Jiang, JW Shou, LK You, W Han, H Pan, Z Liu Math Biosci Eng 17 (3), 2557-2568, 2020 | 5 | 2020 |
| The benefit of anti-angiogenic therapy in EGFR exon 21 L858R mutant non-small cell lung cancer patients: a retrospective study L You, X Zheng, D Deng, H Pan, W Han Scientific Reports 12 (1), 14624, 2022 | 4 | 2022 |
| Lymph node involvement in pancreatic neuroendocrine tumors: significance as a predictor of survival L Yu, R Zhao, X Han, J Shou, L You, H Jiang, X Zhou, Z Liu, H Pan, ... Journal of Bio-X Research 2 (01), 25-33, 2019 | 4 | 2019 |
| Gender-associated differences of lung cancer and mechanism X Xin, L Yongde, T Hexiao, C Guang, JU Sheng, YOU Liangkun Zhongguo Fei Ai Za Zhi 14 (7), 2011 | 4 | 2011 |
| Hemophagocytic lymphohistiocytosis following pembrolizumab and bevacizumab combination therapy for cervical cancer: a case report and systematic review C Zhai, X Jin, L You, N Yan, J Dong, S Qiao, Y Zhong, Y Zheng, H Pan BMC geriatrics 24 (1), 32, 2024 | 2 | 2024 |
